These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9092508)

  • 1. Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region.
    Fledelius C; Johnsen AH; Cloos PA; Bonde M; Qvist P
    J Biol Chem; 1997 Apr; 272(15):9755-63. PubMed ID: 9092508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoaspartyl bond formation within N-terminal sequences of collagen type I: implications for their use as markers of collagen degradation.
    Brady JD; Ju J; Robins SP
    Clin Sci (Lond); 1999 Feb; 96(2):209-15. PubMed ID: 9918902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations.
    Garnero P; Schott AM; Prockop D; Chevrel G
    Bone; 2009 Mar; 44(3):461-6. PubMed ID: 19071236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential.
    Cloos PA; Fledelius C
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):473-80. PubMed ID: 10642504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.
    Garnero P; Fledelius C; Gineyts E; Serre CM; Vignot E; Delmas PD
    J Bone Miner Res; 1997 Sep; 12(9):1407-15. PubMed ID: 9286756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new monoclonal antibody ELISA for detection and characterization of C-telopeptide fragments of type I collagen in urine.
    Srivastava AK; MacFarlane G; Srivastava VP; Mohan S; Baylink DJ
    Calcif Tissue Int; 2001 Dec; 69(6):327-36. PubMed ID: 11800229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone.
    Alexandersen P; Peris P; Guañabens N; Byrjalsen I; Alvarez L; Solberg H; Cloos PA
    J Bone Miner Res; 2005 Apr; 20(4):588-95. PubMed ID: 15765177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular site specificity of pyridinoline and pyrrole cross-links in type I collagen of human bone.
    Hanson DA; Eyre DR
    J Biol Chem; 1996 Oct; 271(43):26508-16. PubMed ID: 8900119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone.
    Cloos PA; Lyubimova N; Solberg H; Qvist P; Christiansen C; Byrjalsen I; Christgau S
    Clin Lab; 2004; 50(5-6):279-89. PubMed ID: 15209436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of serum and urinary C-terminal telopeptide of type I collagen in aging, menopause and osteoporosis.
    Kawana K; Takahashi M; Hoshino H; Kushida K
    Clin Chim Acta; 2002 Feb; 316(1-2):109-15. PubMed ID: 11750280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the clinical performance of the immunoenzymometric assays for N-terminal and C-terminal type I collagen telopeptides and the HPLC assay for pyridinium cross-links.
    Bettica P; Masino M; Cucinotta E; Vago T; Norbiato G; Moro L; Suarez KN; Romanello M; Bevilacqua M
    Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):63-8. PubMed ID: 9156570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine.
    Hanson DA; Weis MA; Bollen AM; Maslan SL; Singer FR; Eyre DR
    J Bone Miner Res; 1992 Nov; 7(11):1251-8. PubMed ID: 1466251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racemization and isomerization of type I collagen C-telopeptides in human bone and soft tissues: assessment of tissue turnover.
    Gineyts E; Cloos PA; Borel O; Grimaud L; Delmas PD; Garnero P
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):481-5. PubMed ID: 10642505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a monoclonal antibody to urinary degradation products from the C-terminal telopeptide alpha 1 chain of type I collagen. Application in an enzyme immunoassay and comparison to CrossLaps ELISA.
    Fledelius C; Kolding I; Qvist P; Bonde M; Hassager C; Reginster JY; Hejgaard J; Frøokiaer H; Christiansen C
    Scand J Clin Lab Invest; 1997 Feb; 57(1):73-83. PubMed ID: 9127460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency.
    Kamel S; Brazier M; Rogez JC; Vincent O; Maamer M; Desmet G; Sebert JL
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3717-21. PubMed ID: 8855828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K.
    Sassi ML; Eriksen H; Risteli L; Niemi S; Mansell J; Gowen M; Risteli J
    Bone; 2000 Apr; 26(4):367-73. PubMed ID: 10719280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen.
    Rosenquist C; Fledelius C; Christgau S; Pedersen BJ; Bonde M; Qvist P; Christiansen C
    Clin Chem; 1998 Nov; 44(11):2281-9. PubMed ID: 9799755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differently cross-linked and uncross-linked carboxy-terminal telopeptides of type I collagen in human mineralised bone.
    Eriksen HA; Sharp CA; Robins SP; Sassi ML; Risteli L; Risteli J
    Bone; 2004 Apr; 34(4):720-7. PubMed ID: 15050904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of C-telopeptide enzyme-linked immunoassay for measurement of bone resorption in mouse serum.
    Srivastava AK; Bhattacharyya S; Castillo G; Miyakoshi N; Mohan S; Baylink DJ
    Bone; 2000 Oct; 27(4):529-33. PubMed ID: 11033448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.